-

Manhattan Associates Reports First Quarter Results

RPO Increased 24% over Prior Year

ATLANTA--(BUSINESS WIRE)--Leading Supply Chain and Omnichannel Commerce Solutions provider Manhattan Associates Inc. (NASDAQ: MANH) today reported revenue of $282.2 million for the first quarter ended March 31, 2026, compared to $262.8 million in Q1 2025. GAAP diluted earnings per share for Q1 2026 was $0.82 compared to $0.85 in Q1 2025. Non-GAAP adjusted diluted earnings per share for Q1 2026 was $1.24 compared to $1.19 in Q1 2025.

“Manhattan is off to a strong start to 2026. On solid and broad-based demand, we accelerated our Q1 revenue growth and delivered better than expected bookings,” said Manhattan Associates president and CEO Eric Clark.

“While macro volatility persists, Manhattan’s fundamentals are solid. With a strong pipeline across our product suite, numerous opportunities to drive growth, and our unmatched ability to consistently deliver leading innovation to the supply chain commerce universe, we are optimistic about our long-term growth opportunity,” Mr. Clark concluded.

FIRST QUARTER 2026 FINANCIAL SUMMARY:

  • Consolidated total revenue was $282.2 million for Q1 2026, compared to $262.8 million for Q1 2025.
    • Cloud subscription revenue was $117.1 million for Q1 2026, compared to $94.3 million for Q1 2025.
    • License revenue was $2.2 million for Q1 2026, compared to $9.3 million for Q1 2025.
    • Services revenue was $125.7 million for Q1 2026, compared to $121.1 million for Q1 2025.
  • GAAP diluted earnings per share was $0.82 for Q1 2026, compared to $0.85 for Q1 2025.
  • Adjusted diluted earnings per share, a non-GAAP measure, was $1.24 for Q1 2026, compared to $1.19 for Q1 2025.
  • GAAP operating income was $64.9 million for Q1 2026, compared to $63.2 million for Q1 2025.
  • Adjusted operating income, a non-GAAP measure, was $91.5 million for Q1 2026, compared to $91.3 million for Q1 2025.
  • Cash flow from operations was $84.0 million for Q1 2026, compared to $75.3 million for Q1 2025. Days Sales Outstanding was 72 days at March 31, 2026, and 73 days at December 31, 2025.
  • Cash totaled $226.1 million at March 31, 2026, compared to $328.7 million at December 31, 2025.
  • RPO increased to $2.35 billion as of March 31, 2026, compared to $2.23 billion as of December 31, 2025.
  • During the three months ended March 31, 2026, the Company repurchased 1,043,312 shares of Manhattan Associates common stock under the share repurchase program authorized by our Board of Directors for a total investment of $150.0 million. In March 2026, our Board of Directors approved an increase to the Company’s share repurchase authority from $100 million to $500 million. As of the end of the quarter, approximately $350.0 million remained under the existing March 2026 repurchase authority.

2026 GUIDANCE

Manhattan Associates provides the following revenue, operating margin, and diluted earnings per share guidance for the full year 2026:

 

Guidance Range - 2026 Full Year

($'s in millions, except operating margin and EPS)

$ Range

 

% Growth Range

 

 

 

 

 

 

 

 

 

Total revenue

$1,147

 

 

$1,157

 

 

6

%

 

7

%

 

 

 

 

 

 

 

 

 

 

 

 

Operating Margin:

 

 

 

 

 

 

 

 

 

GAAP operating margin

24.6

%

 

24.9

%

 

 

 

 

 

 

Equity-based compensation

10.3

%

 

10.2

%

 

 

 

 

 

 

Adjusted operating margin(1)

34.9

%

 

35.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share (EPS):

 

 

 

 

 

 

 

 

 

GAAP EPS

$3.55

 

 

$3.63

 

 

-1

%

 

1

%

 

 

Equity-based compensation

1.70

 

 

1.70

 

 

 

 

 

 

 

Tax deficiency of stock awards vested (2)

0.04

 

 

0.04

 

 

 

 

 

 

 

Adjusted EPS(1)

$5.29

 

 

$5.37

 

 

5

%

 

6

%

 

 

 

 

 

 

(1) Adjusted operating margin and adjusted EPS are non-GAAP measures that exclude the impact of equity-based compensation,

 

 

expense related to an unusual health insurance claim, restructuring expense, and the related income tax effects, if applicable.

 

(2) The Company expects the tax deficiency on stock vesting to occur primarily in the first quarter of 2026.

 

Manhattan Associates currently intends to make public certain expectations with respect to future financial performance. Those statements, including the guidance provided above, are forward looking. Actual results may differ materially. See our cautionary note regarding “forward-looking statements” below.

Manhattan Associates will make this earnings release and a recording of the conference call referenced below available on the investor relations section of the Manhattan Associates website at ir.manh.com. Following publication of this earnings release, any expectations with respect to future financial performance contained in this release or the conference call, including the guidance, should be considered historical only, and Manhattan Associates disclaims any obligation to update them.

CONFERENCE CALL

Manhattan Associates’ conference call regarding its first quarter financial results will be held today, April 21, 2026, at 4:30 p.m. Eastern Time. The Company will also discuss its business and expectations for the year and next quarter in additional detail during the call. We invite investors to a live webcast of the conference call through the Investor Relations section of the Manhattan Associates website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. The Internet webcast will be available until Manhattan Associates’ second quarter 2026 earnings release.

GAAP VERSUS NON-GAAP PRESENTATION

Manhattan Associates provides adjusted operating income and margin, adjusted income tax provision, adjusted net income, and adjusted diluted earnings per share in this press release as additional information regarding the Company’s historical and projected operating results. These measures are not in accordance with, or alternatives to, GAAP, and may be different from similarly titled non-GAAP measures used by other companies. The Company believes the presentation of these non-GAAP financial measures facilitates investors’ ability to understand and compare the Company’s results and guidance, because the measures provide supplemental information in evaluating the operating results of its business, as distinct from results that include items not indicative of ongoing operating results, and because the Company believes its peers typically publish similar non-GAAP measures. This release should be read in conjunction with the Company’s Form 8-K earnings release filing for the three months ended March 31, 2026.

Non-GAAP adjusted operating income and margin, adjusted income tax provision, adjusted net income, and adjusted diluted earnings per share exclude the impact of equity-based compensation, an expense – net of insurance recoveries, related to an unusual health insurance claim, and restructuring expense – net of income tax effects, collectively. They also exclude the tax benefits or deficiencies of vested stock awards caused by differences in the amount deductible for tax purposes from the compensation expense recorded for financial reporting purposes. We include reconciliations of the Company’s GAAP financial measures to non-GAAP adjustments in the supplemental information attached to this release.

ABOUT MANHATTAN ASSOCIATES

Manhattan Associates is a global technology leader, providing supply chain and omnichannel commerce solutions with unmatched AI capabilities. We design, build and offer best-in-class, AI-powered, cloud-based solutions that drive resilience and efficiency for businesses. We enable enterprises to uniquely unify front-end sales with back-end supply chain execution.

Our commitment to innovation, cloud-native platform and API-first architecture create simpler experiences and faster paths to value for our customers. We empower them to preempt and react to emerging trends and global disruptions with technical expertise and operational confidence, transforming challenges into competitive advantage. For more information, please visit www.manh.com.

This press release contains “forward-looking statements” relating to Manhattan Associates, Inc. Forward-looking statements in this press release include, without limitation, the information set forth under “2026 Guidance” and statements identified by words such as “may,” “expect,” “forecast,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “project,” “estimate,” and similar expressions. Prospective investors are cautioned that any of those forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by those forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by those forward-looking statements are: economic conditions, including as a result of global instability due to military conflict, including the military conflict involving the United States, Israel, and Iran, as well as the ongoing war between Russia and Ukraine, disruption and transformation in the retail sector and our vertical markets; delays in product development; competitive and pricing pressures; software errors and information technology failures, disruption and security breaches; risks related to our products’ technology and customer implementations; risks associated with our use of generative and agentic artificial intelligence; and the other risk factors set forth in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and in Item 1A of Part II in subsequent Quarterly Reports on Form 10-Q. Manhattan Associates undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results.

 

MANHATTAN ASSOCIATES, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(in thousands, except per share amounts)

 

 

 

Three Months Ended March 31,

 

 

2026

 

2025

 

 

(unaudited)

 

(unaudited)

Revenue:

 

 

 

 

Cloud subscriptions

 

$117,123

 

$94,306

Software license

 

2,234

 

9,292

Maintenance

 

30,592

 

32,144

Services

 

125,717

 

121,127

Hardware

 

6,549

 

5,918

Total revenue

 

282,215

 

262,787

Costs and expenses:

 

 

 

 

Cost of cloud subscriptions, maintenance and services

 

126,077

 

114,358

Cost of software license

 

564

 

209

Research and development

 

37,346

 

35,298

Sales and marketing

 

27,752

 

21,061

General and administrative

 

23,706

 

24,219

Depreciation and amortization

 

1,833

 

1,541

Restructuring expense

 

-

 

2,929

Total costs and expenses

 

217,278

 

199,615

Operating income

 

64,937

 

63,172

Other income, net

 

4,337

 

1,337

Income before income taxes

 

69,274

 

64,509

Income tax provision

 

19,979

 

11,927

Net income

 

$49,295

 

$52,582

 

 

 

 

 

Basic earnings per share

 

$0.83

 

$0.86

Diluted earnings per share

 

$0.82

 

$0.85

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

Basic

 

59,688

 

60,870

Diluted

 

60,038

 

61,527

Reconciliation of Selected GAAP to Non-GAAP Measures

(in thousands, except per share amounts)

 

 

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

 

 

 

 

 

 

Operating income

 

 

$64,937

 

 

$63,172

 

Equity-based compensation (a)

 

 

26,524

 

 

28,826

 

Unusual health insurance claim (c)

 

 

-

 

 

(3,658

)

Restructuring expense (d)

 

 

-

 

 

2,929

 

Adjusted operating income (Non-GAAP)

 

 

$91,461

 

 

$91,269

 

 

 

 

 

 

 

Income tax provision

 

 

$19,979

 

 

$11,927

 

Equity-based compensation (a)

 

 

3,698

 

 

4,340

 

Tax (deficiency) benefit of stock awards vested (b)

 

 

(2,177

)

 

3,542

 

Unusual health insurance claim (c)

 

 

-

 

 

(883

)

Restructuring expense (d)

 

 

-

 

 

707

 

Adjusted income tax provision (Non-GAAP)

 

 

$21,500

 

 

$19,633

 

 

 

 

 

 

 

Net income

 

 

$49,295

 

 

$52,582

 

Equity-based compensation (a)

 

 

22,826

 

 

24,486

 

Tax deficiency (benefit) of stock awards vested (b)

 

 

2,177

 

 

(3,542

)

Unusual health insurance claim (c)

 

 

-

 

 

(2,775

)

Restructuring expense (d)

 

 

-

 

 

2,222

 

Adjusted net income (Non-GAAP)

 

 

$74,298

 

 

$72,973

 

 

 

 

 

 

 

Diluted EPS

 

 

$0.82

 

 

$0.85

 

Equity-based compensation (a)

 

 

0.38

 

 

0.40

 

Tax deficiency (benefit) of stock awards vested (b)

 

 

0.04

 

 

(0.06

)

Unusual health insurance claim (c)

 

 

-

 

 

(0.05

)

Restructuring expense (d)

 

 

-

 

 

0.04

 

Adjusted diluted EPS (Non-GAAP)

 

 

$1.24

 

 

$1.19

 

 

 

 

 

 

 

Fully diluted shares

 

 

60,038

 

 

61,527

 

(a)

Adjusted results exclude all equity-based compensation, as detailed below, to facilitate comparison with our peers and for the other reasons explained in our Current Report on Form 8-K filed with the SEC. We do not receive a GAAP tax benefit for a portion of our equity-based compensation, mainly because of Section 162(m) of the Internal Revenue Code, which limits tax deductions for compensation granted to certain executives.

 

 

 

Three Months Ended March 31,

 

 

2026

2025

 

 

 

 

 

Cost of services

 

 

$11,586

 

$11,425

Research and development

 

 

6,387

 

5,958

Sales and marketing

 

3,668

 

2,306

General and administrative

 

4,883

 

9,137

Total equity-based compensation

 

 

$26,524

 

$28,826

(b)

Adjustments represent the excess tax benefits and tax deficiencies of the equity awards vested during the period. Excess tax benefits (deficiencies) occur when the amount deductible on our tax return for an equity award is more (less) than the cumulative compensation cost recognized for financial reporting purposes. As discussed above, we exclude equity-based compensation from adjusted non-GAAP results to be consistent with other companies in the software industry and for the other reasons explained in our Current Report on Form 8-K filed with the SEC. Therefore, we also exclude the related tax benefit (expense) generated upon their vesting.

(c)

In the fourth quarter of 2024, we recorded $7.0 million of expense for an unusual health insurance claim. During the first quarter of 2025, we received an insurance recovery of $4.7 million for this claim, partially offset by $1.0 million of ongoing expense for the claim. During the second quarter of 2025, we recorded an additional $3.0 million of expense for this unusual health insurance claim. During the fourth quarter of 2025, we settled the remaining balance of the claim and recorded $6.2 million of benefit as the final payment was much lower than the cost estimates previously provided by our health insurance provider. Based on the uncommonly large magnitude and nature of the claim and timing of related insurance recoveries, we do not believe that this expense reflects our normal operating activities, and we have excluded the amount from adjusted non-GAAP results.

(d)

In January 2025, the Company eliminated about 100 positions to align our services capacity with customer demand, which had been impacted by macro-economic uncertainty. We recorded pre-tax restructuring expense in the first quarter of 2025 of approximately $2.9 million. The expense primarily consists of employee severance and outplacement services. We do not believe that the expense is a common cost that resulted from normal operating activities, and thus we have excluded the amount from adjusted non-GAAP results.

MANHATTAN ASSOCIATES, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

 

 

 

March 31, 2026

 

 

December 31, 2025

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

226,133

 

 

$

328,747

 

Accounts receivable, net

 

 

227,110

 

 

 

214,679

 

Prepaid expenses and other current assets

 

 

62,573

 

 

 

39,912

 

Total current assets

 

 

515,816

 

 

 

583,338

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

25,269

 

 

 

23,120

 

Operating lease right-of-use assets

 

 

47,431

 

 

 

50,443

 

Goodwill, net

 

 

62,241

 

 

 

62,244

 

Deferred income taxes

 

 

43,763

 

 

 

75,900

 

Other assets

 

 

46,018

 

 

 

44,343

 

Total assets

 

$

740,538

 

 

$

839,388

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

22,415

 

 

$

22,182

 

Accrued compensation and benefits

 

 

58,415

 

 

 

69,309

 

Accrued and other liabilities

 

 

30,571

 

 

 

26,570

 

Deferred revenue

 

 

355,909

 

 

 

337,049

 

Income taxes payable

 

 

90

 

 

 

803

 

Total current liabilities

 

 

467,400

 

 

 

455,913

 

 

 

 

 

 

 

 

Operating lease liabilities, long-term

 

 

55,685

 

 

 

56,180

 

Other non-current liabilities

 

 

12,278

 

 

 

12,530

 

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

 

 

 

Preferred stock, no par value; 20,000,000 shares authorized, no shares issued or outstanding in 2026 and 2025

 

 

-

 

 

 

-

 

Common stock, $0.01 par value; 200,000,000 shares authorized; 59,164,492 and 59,845,291 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively

 

 

591

 

 

 

598

 

Retained earnings

 

 

240,577

 

 

 

345,097

 

Accumulated other comprehensive loss

 

 

(35,993

)

 

 

(30,930

)

Total shareholders' equity

 

 

205,175

 

 

 

314,765

 

Total liabilities and shareholders' equity

 

$

740,538

 

 

$

839,388

 

MANHATTAN ASSOCIATES, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(in thousands)

 

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(unaudited)

 

Operating activities:

 

 

 

 

 

 

Net income

 

$

49,295

 

 

$

52,582

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

1,833

 

 

 

1,541

 

Equity-based compensation

 

 

26,524

 

 

 

28,826

 

Gain on disposal of equipment

 

 

(156

)

 

 

(98

)

Deferred income taxes

 

 

31,854

 

 

 

2,133

 

Unrealized foreign currency (gain) loss

 

 

(2,212

)

 

 

781

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable, net

 

 

(13,217

)

 

 

(3,321

)

Other assets

 

 

(9,651

)

 

 

(11,959

)

Accounts payable, accrued and other liabilities

 

 

(4,044

)

 

 

(18,807

)

Income taxes

 

 

(15,790

)

 

 

6,482

 

Deferred revenue

 

 

19,609

 

 

 

17,100

 

Net cash provided by operating activities

 

 

84,045

 

 

 

75,260

 

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

 

Purchase of property and equipment

 

 

(4,103

)

 

 

(891

)

Net cash used in investing activities

 

 

(4,103

)

 

 

(891

)

 

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

 

Repurchase of common stock

 

 

(179,387

)

 

 

(136,447

)

Net cash used in financing activities

 

 

(179,387

)

 

 

(136,447

)

 

 

 

 

 

 

 

Foreign currency impact on cash

 

 

(3,169

)

 

 

1,721

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

 

(102,614

)

 

 

(60,357

)

Cash and cash equivalents at beginning of period

 

 

328,747

 

 

 

266,230

 

Cash and cash equivalents at end of period

 

$

226,133

 

 

$

205,873

 

MANHATTAN ASSOCIATES, INC.

SUPPLEMENTAL INFORMATION

1. GAAP and adjusted earnings per share by quarter are as follows:

 

2025

 

 

 

 

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

GAAP Diluted EPS

$0.85

 

 

$0.93

 

$0.96

 

 

$0.86

 

 

$3.60

 

 

$0.82

Adjustments to GAAP:

 

 

 

 

 

 

 

 

 

 

 

Equity-based compensation

0.40

 

 

0.35

 

0.40

 

 

0.43

 

 

1.57

 

 

0.38

Tax deficiency (benefit) of stock awards vested

(0.06

)

 

-

 

(0.01

)

 

-

 

 

(0.06

)

 

0.04

Restructuring expense

(0.05

)

 

0.04

 

-

 

 

(0.08

)

 

(0.09

)

 

-

Unusual health insurance claim

0.04

 

 

-

 

-

 

 

-

 

 

0.04

 

 

-

Adjusted Diluted EPS

$1.19

 

 

$1.31

 

$1.36

 

 

$1.21

 

 

$5.06

 

 

$1.24

Fully Diluted Shares

61,527

 

 

61,074

 

60,954

 

 

60,642

 

 

61,054

 

 

60,038

2. Revenues and operating income by reportable segment are as follows (in thousands):

 

2025

 

 

 

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

Revenue:

Americas

$194,615

 

 

$206,606

 

$206,659

 

$202,546

 

 

$810,426

 

 

$214,550

EMEA

55,542

 

 

52,301

 

53,975

 

53,978

 

 

215,796

 

 

53,663

APAC

12,630

 

 

13,514

 

15,161

 

13,865

 

 

55,170

 

 

14,002

 

$262,787

 

 

$272,421

 

$275,795

 

$270,389

 

 

$1,081,392

 

 

$282,215

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Operating Income:

Americas

$33,862

 

 

$48,051

 

$45,783

 

$39,875

 

 

$167,571

 

 

$39,005

EMEA

23,703

 

 

19,807

 

22,877

 

21,686

 

 

88,073

 

 

19,670

APAC

5,607

 

 

5,930

 

7,168

 

5,451

 

 

24,156

 

 

6,262

 

$63,172

 

 

$73,788

 

$75,828

 

$67,012

 

 

$279,800

 

 

$64,937

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments (pre-tax):

Americas:

 

 

 

 

 

 

 

 

 

 

 

Equity-based compensation

$28,826

 

 

$24,275

 

$27,577

 

$30,585

 

 

$111,263

 

 

$26,524

Unusual health insurance claim

(3,658

)

 

3,000

 

-

 

(6,224

)

 

(6,882

)

 

-

Restructuring expense

2,929

 

 

8

 

-

 

-

 

 

2,937

 

 

-

 

$28,097

 

 

$27,283

 

$27,577

 

$24,361

 

 

$107,318

 

 

$26,524

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted non-GAAP Operating Income:

Americas

$61,959

 

 

$75,334

 

$73,360

 

$64,236

 

 

$274,889

 

 

$65,529

EMEA

23,703

 

 

19,807

 

22,877

 

21,686

 

 

88,073

 

 

19,670

APAC

5,607

 

 

5,930

 

7,168

 

5,451

 

 

24,156

 

 

6,262

$91,269

 

 

$101,071

 

$103,405

 

$91,373

 

 

$387,118

 

 

$91,461

3. Impact of Currency Fluctuation

The following table reflects the increases (decreases) in the results of operations for each period attributable to the change in foreign currency exchange rates from the prior period as well as foreign currency gains (losses) included in other income, net for each period (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

 

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

Revenue

$(1,591

)

 

$2,724

 

 

$2,652

 

$3,833

 

$7,618

 

$5,975

Costs and expenses

(1,966

)

 

1,180

 

 

738

 

906

 

858

 

2,646

Operating income

375

 

 

1,544

 

 

1,914

 

2,927

 

6,760

 

3,329

Foreign currency gains (losses) in other income

131

 

 

(65

)

 

1,596

 

9

 

1,671

 

3,229

 

$506

 

 

$1,479

 

 

$3,510

 

$2,936

 

$8,431

 

$6,558

Manhattan Associates has a large research and development center in Bangalore, India. The following table reflects the increases (decreases) in the financial results for each period attributable to changes in the Indian Rupee exchange rate (in thousands):

 

2025

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

Operating income

$785

 

$514

 

$832

 

$1,409

 

$3,540

 

$1,045

Foreign currency gains (losses) in other income

15

 

140

 

1,978

 

742

 

2,875

 

3,449

Total impact of changes in the Indian Rupee

$800

 

$654

 

$2,810

 

$2,151

 

$6,415

 

$4,494

4. Other income includes the following components (in thousands):

 

2025

 

 

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

Interest income

$1,101

 

$852

 

 

$1,007

 

$1,429

 

 

$4,389

 

$951

Foreign currency gains (losses)

130

 

(65

)

 

1,597

 

9

 

 

1,671

 

3,229

Other non-operating income (expense)

106

 

(72

)

 

-

 

(1

)

 

33

 

157

Total other income (loss)

$1,337

 

$715

 

 

$2,604

 

$1,438

 

 

$6,094

 

$4,337

5. Capital expenditures are as follows (in thousands):

 

2025

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

Capital expenditures

$891

 

$3,980

 

$5,928

 

$4,658

 

$15,457

 

$4,103

6. Stock Repurchase Activity (in thousands):

 

2025

 

2026

 

1st Qtr

 

2nd Qtr

 

3rd Qtr

 

4th Qtr

 

Full Year

 

1st Qtr

Shares purchased under publicly-announced buy-back program

539

 

263

 

233

 

416

 

1,451

 

1,043

Shares withheld for taxes due upon vesting of restricted stock

179

 

3

 

8

 

2

 

192

 

198

Total shares purchased

718

 

266

 

241

 

418

 

1,643

 

1,241

 

 

 

 

 

 

 

 

 

 

 

 

Total cash paid for shares purchased under publicly-announced buy-back program

$100,000

 

$49,596

 

$49,947

 

$74,996

 

$274,539

 

$149,983

Total cash paid for shares withheld for taxes due upon vesting of restricted stock

36,447

 

595

 

1,602

 

398

 

39,042

 

29,404

Total cash paid for excise tax

-

 

-

 

-

 

1,581

 

1,581

 

-

Total cash paid for shares repurchased

$136,447

 

$50,191

 

$51,549

 

$76,975

 

$315,162

 

$179,387

7. Remaining Performance Obligations

We disclose revenue that we expect to recognize from our remaining performance obligations ("RPO"). Over 98% of our RPO represents cloud native subscriptions with non-cancelable terms greater than one year (including cloud-deferred revenue as well as amounts we will invoice and recognize as revenue from our performance of cloud services in future periods). Maintenance contracts are typically one year and not included in the RPO. Our RPO as of the end of each period appears below (in thousands):

 

March 31, 2025

 

June 30, 2025

 

September 30, 2025

 

December 31, 2025

 

March 31, 2026

Remaining Performance Obligations

$1,891,384

 

$2,013,495

 

$2,076,628

 

$2,232,234

 

$2,347,952

 

Contacts

Michael Bauer
VP, Investor Relations
Manhattan Associates, Inc.
678-597-7538
mbauer@manh.com

Devika Goel
Director, Corporate Communications
Manhattan Associates, Inc.
678-597-6754
dgoel@manh.com

Manhattan Associates Inc.

NASDAQ:MANH
Details
Headquarters: Atlanta, Georgia
Website: www.manh.com
CEO: Eric Clark
Employees: 4000+
Organization: PUB
Revenues: $1 Billion (2024)

Release Summary
Manhattan Associates announces Q1 2026 earnings results.
Release Versions

Contacts

Michael Bauer
VP, Investor Relations
Manhattan Associates, Inc.
678-597-7538
mbauer@manh.com

Devika Goel
Director, Corporate Communications
Manhattan Associates, Inc.
678-597-6754
dgoel@manh.com

More News From Manhattan Associates Inc.

Manhattan Named a Leader in 2026 Gartner® Magic Quadrant™ for Transportation Management Systems

ATLANTA--(BUSINESS WIRE)--Manhattan has been named a Leader in Gartner's Magic Quadrant for TMS....

Manhattan Associates’ 2026 Unified Commerce Benchmark Reveals the High Price of Standing Still in Retail

ATLANTA--(BUSINESS WIRE)--Manhattan Announces Findings of its 2026 Global Unified Commerce Benchmark....
Back to Newsroom